M Yamaya Selected Research

M Yamaya Research Topics

Disease

7	Infections 03/2007 - 03/2000
5	Inflammation (Inflammations) 03/2007 - 03/2000
5	Asthma (Bronchial Asthma) 05/2004 - 06/2000
4	Pneumonia (Pneumonitis) 04/2006 - 01/2001
3	Cough 02/2002 - 07/2000
3	Virus Diseases (Viral Diseases) 06/2001 - 03/2000
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2007 - 09/2001
2	Common Cold 03/2007 - 09/2001
1	Hyperplasia 01/2008
1	Atherosclerosis 04/2006
1	Lung Diseases (Lung Disease) 09/2002
1	Airway Obstruction (Choking) 07/2001
1	Stroke (Strokes) 01/2001
1	Vascular Diseases (Vascular Disease) 01/2001
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2000
1	Deglutition Disorders (Dysphagia) 07/2000
1	Syncope (Fainting) 07/2000
1	Emphysema 01/2000
1	Pulmonary Emphysema 01/2000

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 03/2007 - 03/2000
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2007 - 03/2000
3	Viral RNAIBA 03/2007 - 03/2000
3	RNA (Ribonucleic Acid)IBA 03/2007 - 06/2001
3	Messenger RNA (mRNA)IBA 03/2007 - 03/2000
2	InterleukinsIBA 07/2006 - 03/2000
2	Interleukin-8 (Interleukin 8)IBA 07/2006 - 03/2000
2	Carbon MonoxideIBA 09/2002 - 03/2001
2	GlucocorticoidsIBA 09/2002 - 03/2000
2	Dopamine (Intropin)FDA LinkGeneric 02/2002 - 01/2001
2	Erythromycin (Erycette)FDA LinkGeneric 09/2001 - 06/2000
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2001 - 03/2001
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2000 - 03/2000
1	Interleukin-13IBA 01/2008
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 03/2007
1	bu-zhong-yi-qi-tangIBA 03/2007
1	NF-kappa B (NF-kB)IBA 07/2006
1	Pharmaceutical PreparationsIBA 07/2006
1	Expectorants (Mucolytics)IBA 07/2006
1	Heme (Haem)IBA 04/2006
1	Oxidants (Oxidizing Agents)IBA 04/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2004
1	Culture MediaIBA 05/2004
1	Chemokine CCL5IBA 05/2004
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2002
1	C-Reactive ProteinIBA 09/2002
1	Capsaicin (Zostrix)FDA Link 02/2002
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2002
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2002
1	Cholinergic Agents (Cholinergics)IBA 02/2002
1	5-HT1A Serotonin ReceptorIBA 02/2002
1	Cimetidine (Biomet)FDA LinkGeneric 02/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2002
1	Atropine FDA LinkGeneric 02/2002
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 02/2002
1	Pyrilamine (Mepyramine)FDA Link 02/2002
1	Histamine H2 AntagonistsIBA 02/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2002
1	Serotonin (5 Hydroxytryptamine)IBA 02/2002
1	SCH 23390IBA 02/2002
1	hydroxide ionIBA 02/2002
1	SteroidsIBA 11/2001
1	bafilomycin AIBA 06/2001
1	Cell Adhesion MoleculesIBA 06/2001
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 06/2001
1	LDL Receptors (LDL Receptor)IBA 03/2001
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2001
1	Substance PIBA 01/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2001
1	Amantadine (Aman)FDA LinkGeneric 01/2001
1	imidaprilIBA 07/2000
1	bafilomycin A1IBA 06/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2000
1	Interleukin-6 (Interleukin 6)IBA 03/2000
1	Proteins (Proteins, Gene)FDA Link 03/2000
1	Heme Oxygenase-1IBA 01/2000
1	SmokeIBA 01/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2000

Therapy/Procedure

4	Therapeutics 09/2001 - 06/2000
1	Activities of Daily Living (ADL) 11/2000